| Trial ID: | L0882 |
| Source ID: | IRCT2014010715879N3
|
| Associated Drug: |
Lactulose
|
| Title: |
Study of lactulose effects in the treatment of non alcoholic fatty liver disease in comparison with vitamin E: A randomized, clinical trial
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver disease. <br>Non alcoholic fatty liver disease;Non alcoholic fatty liver disease
|
| Interventions: |
Intervention 1: Patients in the intervention group receive 20- 30cc lactulose daily for one month. Lactulose syrup (or Laxilose??, 10 g lactulose/15 mL, Alborzdaru) is a synthetic sugar used to treat constipation. In the colon, lactulose is metabolized p
|
| Outcome Measures: |
Liver size. Timepoint: Baseline and one month after starting the study. Method of measurement: Ultrasound sonography.Intestinal probiotic count. Timepoint: Baseline and one month after starting the study. Method of measurement: Pour plate technique.;Drug complications. Timepoint: One month after starting the study. Method of measurement: Ask the patient.
|
| Sponsor/Collaborators: |
Vice chancellor for research, Tabriz university of medical sciences
|
| Gender: |
All
|
| Age: |
30 years70 years
|
| Phases: |
Not applicable
|
| Enrollment: |
40
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Patients will be randomly divided into two groups using the software Randlist 1.2.
|
| Start Date: |
08/02/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/15013
|
